Credentials
From Lab Floor to CRA Approval—Innovation That Holds Up in Audit
Led by Dr. Alec Zhou, Ph.D., with over 20 years of R&D leadership in cannabis, food, biotech and chemical processing.
Inventor of a patented stem-removal process. Expert in TRIZ, CFD, pilot scale-up, and SR&ED strategy.
We help clients structure and scale their innovation—so it performs in real life and passes audit.
Tools That Power SR&ED-Ready Innovation
Built for engineering rigor, CRA compliance, and innovation velocity
- TRIZ (Contradiction Matrix, ARIZ) – to break out of “just optimise” loops and uncover real advancement
- Cognitive Bias Audit Toolkit – to remove the subtle thinking traps that hide uncertainty or inflate conclusions
- Live Engineering Log™ Framework – to capture contemporaneous documentation CRA reviewers trust
- AI tools – to design better hypotheses and reduce uncertainty faster
- Design of Experiments (DOE) – to validate learning with scientific credibility
Case Snapshot: Potency Precision in Infused Edibles
Problem
A food R&D team needed to meet strict regulatory requirements by maintaining cannabinoid potency in edibles within 99.75% accuracy.
Their initial solution—reducing batch size—improved precision but led to excessive waste and under-utilized production capacity.
TRIZ Insight
Using the Contradiction Matrix, we surfaced a hidden conflict:
“Reducing batch size improves control, but increases waste cost.”
This revealed a new path forward—one that maintained dosing precision without sacrificing scale.
Bias Removed
The team had originally classified the work as quality assurance, and excluded it from their SR&ED claim.
We reframed it as a technological uncertainty around formulation control and process stability—making it fully eligible under SR&ED guidelines.
Outcome
- Production resumed at full capacity
- Potency stayed within the 99.75% target range
- All associated process optimization costs qualified for SR&ED
- No CRA pushback on the claim
“We thought it was just QA compliance testing. Alec showed us it was R&D.”
